Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy

Epilepsia

Volumn 51, Issue 5, 2010, Pages 760-767

  Liimatainen, Suvi ^a   Peltola, Maria ^a   Sabater, Lidia ^b   Fallah, Mahdi ^a   Kharazmi, Elham ^a   Haapala, Anna Maija ^c   Dastidar, Prasun ^a   Knip, Mikael ^a,d   Saiz, Albert ^b   Peltola, Jukka ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Glutamic acid decarboxylase antibody; Immune system; Polyendocrinopathy; Temporal lobe epilepsy

Indexed keywords

AUTOANTIBODY; CRADD PROTEIN; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; EPILEPSY; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC MARKERS; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RADIOIMMUNOASSAY;

EID: 77951536231     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02325.x     Document Type: Article

References (40)

1. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156. (Pubitemid 20315873)
2. Bartolomei F. (1996) Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy? Epilepsia 37:922-926.
3. Butler MH, Solimena M, Dirkx R Jr, Hayday A, De Camilli P. (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178:2097-2106. (Pubitemid 23344866)
4. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399.
5. Commission on Neuroimaging of the International League Against Epilepsy. (1997) Recommendations for neuroimaging of patients with epilepsy. Epilepsia 38:1255-1256.
6. Dalakas MC, Li M, Fujii M, Jacobowitz DM. (2001) Stiff-person syndrome. Quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 57:780-784.
7. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. (1998) Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194-201. (Pubitemid 28374107)
8. Ellis TM, Atkinson MA. (1996) The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 2:148-153. (Pubitemid 26054975)
9. Ganor Y, Goldberg-Stern H, Amrom D, Lerman-Sagie T, Teichberg VI, Pelled D, Futerman AH, Zeev BB, Freilinger M, Verheulpen D, Van Bogaert P, Levite M. (2004) Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin Dev Immunol 11:241-252. (Pubitemid 39423304)
10. Giometto B, Nicolao P, Macucci M, Tavolaro B, Foxon R, Bottazzo GF. (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 8:457. (Pubitemid 28362802)
11. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F. (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225-230. (Pubitemid 32163159)
12. Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ, Schellinger PD, Schwab S, Bardutzky J. (2008) Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 49:914-920. (Pubitemid 351652431)
13. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S. (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 94:14060-14065. (Pubitemid 28009709)
14. Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319.
15. Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ. (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191-195.
16. Kwan P, Brodie MJ. (2002) Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 11:77-84.
17. Levite M, Ganor Y. (2008) Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother 8:1141-1160. (Pubitemid 351962080)
18. Levy LM, Dalakas MC, Floeter MK. (1999) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 131:522-530.
19. Liimatainen S, Peltola M, Fallah M, Kharazmi E, Haapala AM, Peltola J. (2009) The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur J Neurol 16:134-141.
20. Majoie HJ, de Baets M, Renier W, Lang B, Vincent A. (2006) Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 71:135-141. (Pubitemid 44419592)
21. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T. (2002) Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131:179-185.
22. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. (2007) Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 61:544-551. (Pubitemid 47068136)
23. Martinelli P, Pazzaglia P, Montagna P, Coccagna G, Rizzuto N, Simonati S, Lugaresi E. (1978) Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry 41:458-462. (Pubitemid 8323901)
24. Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P. (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 13:155-159.
25. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B. (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730-1736. (Pubitemid 43754401)
26. Nemni R, Braghi S, Natali-Sola MG, Lampasona V, Bonifacio E, Comi G, Canal L. (1994) Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 36:665-667. (Pubitemid 24309382)
27. Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B. (2002) Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109: E50.
28. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-50. (Pubitemid 30460996)
29. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO. (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265:648-651. (Pubitemid 24985559)
30. Saiz A, Arpa J, Sagasta A, Casamitiana R, Zarranz JJ, Tolosa E, Graus F. (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026-1030. (Pubitemid 27456082)
31. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F. (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553-2563.
32. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. (1998) Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293-1297. (Pubitemid 28488755)
33. Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G. (2004) Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 62:517-518. (Pubitemid 38200881)
34. Solimena M, Folli F, Denis-Donini S, Poza G, De Camilli P. (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiffman syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012-1020. (Pubitemid 18095005)
35. Solimena M, Folli F, Aparisi R, Poza G, De Camilli P. (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560. (Pubitemid 20176695)
36. Verrotti A, Greco R, Altobelli E, Latini G, Morgese G, Chiarelli F. (2003) Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients. Clin Exp Med 3:32-36. (Pubitemid 36649011)
37. Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ. (2005) Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol 12:294-299. (Pubitemid 40480981)
38. Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, Fountzoulas K, Giometto B. (2008) Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 41:66-73.
39. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. (2007) Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 78:187-189. (Pubitemid 46220220)
40. Yoshimoto T, Doi M, Fukai N, Izumiyama H, Wago T, Minami I, Uchimura I, Hirata Y. (2005) Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med 44:1174-1177.